{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:17:57Z","timestamp":1791530277660,"version":"4.3.4"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T00:00:00Z","timestamp":1507248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Universit\u00e4tsklinikum T\u00fcbingen in Germany","award":["as clinical sponsor"],"award-info":[{"award-number":["as clinical sponsor"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust (UK)","doi-asserted-by":"crossref","award":["SPHQ14-LOA-255, SPHQ15-LOA-007"],"award-info":[{"award-number":["SPHQ14-LOA-255, SPHQ15-LOA-007"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Bill & Melinda Gates Foundation (US)","award":["SPHQ14-LOA-327-REV1, SPHQ14-LOA-327"],"award-info":[{"award-number":["SPHQ14-LOA-327-REV1, SPHQ14-LOA-327"]}]},{"name":"Bundesministerium f\u00fcr Gesundheit (BMG, Germany)","award":["ZMV I 5-25 14 NIK"],"award-info":[{"award-number":["ZMV I 5-25 14 NIK"]}]},{"name":"The German Center for Infection Research (DZIF)","award":["402-3-04-25"],"award-info":[{"award-number":["402-3-04-25"]}]},{"name":"The Land Baden-W\u00fcrttemberg","award":["Through title: Durchf\u00fchrung einer Ebola-Impfstoffstudie, Implementierung eines Qualit\u00e4tsmanagementsystems"],"award-info":[{"award-number":["Through title: Durchf\u00fchrung einer Ebola-Impfstoffstudie, Implementierung eines Qualit\u00e4tsmanagementsystems"]}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002402","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T17:32:31Z","timestamp":1507311151000},"page":"e1002402","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":67,"title":["Safety and immunogenicity of rVSV\u0394G-ZEBOV-GP Ebola vaccine in adults and children in Lambar\u00e9n\u00e9, Gabon: A phase I randomised trial"],"prefix":"10.1371","volume":"14","author":[{"given":"Selidji T.","family":"Agnandji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 F.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel B.","family":"Bache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis M.","family":"Obiang Mba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Brosnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumeka","family":"Kabwende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Pitzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Staarink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Massinga-Loembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Kr\u00e4hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Biedenkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Katharina","family":"Fehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M.","family":"Staines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Silvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasee","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akim A.","family":"Adegnika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Grobusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Lell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VEBCON Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0066-0634","authenticated-orcid":true,"given":"Sanjeev","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"ref1","year":"2016"},{"key":"ref2","unstructured":"World Health Organization. Ebola situation report\u201430 March 2016. Geneva: World Health Organization; 2016 [cited 2016 Apr 29]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/ebola\/current-situation\/ebola-situation-report-30-march-2016\" xlink:type=\"simple\">http:\/\/apps.who.int\/ebola\/current-situation\/ebola-situation-report-30-march-2016<\/ext-link>."},{"key":"ref3","article-title":"Ebola outbreak 2014\u20132015","year":"2016"},{"issue":"5\u20136","key":"ref4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2051013615611017","article-title":"Clinical development of Ebola vaccines","volume":"3","author":"S Sridhar","year":"2015","journal-title":"Ther Adv vaccines"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21645515.2016.1225637","article-title":"Ebola vaccines in clinical trial: the promising candidates","volume":"13","author":"Y Wang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","year":"2015"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"JA Regules","year":"2017","journal-title":"N Engl J Med"},{"issue":"10068","key":"ref8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"AM Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"17","key":"ref9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1502924","article-title":"Phase 1 trials of rVSV Ebola vaccine in Africa and Europe","volume":"374","author":"ST Agnandji","year":"2016","journal-title":"N Engl J Med"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S1473-3099(15)00154-1","article-title":"The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1\/2 trial","volume":"15","author":"A Huttner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon","volume":"5","author":"P Becquart","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/427994","article-title":"Low seroprevalence of IgG antibodies to Ebola virus in an epidemic zone: Ogooue-Ivindo region, Northeastern Gabon, 1997","volume":"191","author":"RT Heffernan","year":"2005","journal-title":"J Infect Dis"},{"key":"ref13","year":"2015"},{"key":"ref14","year":"2015"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-015-0438-6","article-title":"Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus","volume":"205","author":"V Krahling","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"ref16","year":"2015"},{"issue":"9980","key":"ref17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(15)60858-3","article-title":"Global health security: the wider lessons from the west African Ebola virus disease epidemic","volume":"385","author":"DL Heymann","year":"2015","journal-title":"Lancet"},{"issue":"10009","key":"ref18","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/S0140-6736(15)00946-0","article-title":"Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola","volume":"386","author":"S Moon","year":"2015","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e04395","DOI":"10.7554\/eLife.04395","article-title":"Mapping the zoonotic niche of Ebola virus disease in Africa","volume":"3","author":"DM Pigott","year":"2014","journal-title":"eLife"},{"issue":"24","key":"ref20","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1056\/NEJMp1412166","article-title":"Ebola vaccine\u2014an urgent international priority","volume":"371","author":"R Kanapathipillai","year":"2014","journal-title":"N Engl J Med"},{"issue":"9996","key":"ref21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1473-3099(15)00362-X","article-title":"Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial","volume":"16","author":"MD Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"317","key":"ref23","doi-asserted-by":"crossref","first-page":"317ps24","DOI":"10.1126\/scitranslmed.aad3106","article-title":"Ebola vaccine R&amp;D: filling the knowledge gaps","volume":"7","author":"D Medaglini","year":"2015","journal-title":"Sci Transl Med"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1473-3099(15)00222-4","article-title":"Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort","volume":"15","author":"JE Ledgerwood","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/infdis\/jix189","article-title":"Six-month safety data of recombinant vesicular stomatitis virus-Zaire Ebola virus envelope glycoprotein vaccine in a phase 3 double-blind, placebo-controlled randomized study in healthy adults","volume":"215","author":"SA Halperin","year":"2017","journal-title":"J Infect Dis"},{"key":"ref26","author":"C Howard","year":"1994"},{"issue":"9061","key":"ref27","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(96)12031-6","article-title":"Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women","volume":"349","author":"AJ Tingle","year":"1997","journal-title":"Lancet"},{"issue":"13","key":"ref28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM196903272801302","article-title":"Rubella vaccination in adult females","volume":"280","author":"RE Weibel","year":"1969","journal-title":"N Engl J Med"},{"issue":"385","key":"ref29","doi-asserted-by":"crossref","first-page":"eaaj1701","DOI":"10.1126\/scitranslmed.aaj1701","article-title":"A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa","volume":"9","author":"A Huttner","year":"2017","journal-title":"Sci Transl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ebiom.2017.03.045","article-title":"Dose-dependent T-cell dynamics and cytokine cascade following rVSV-ZEBOV immunization","volume":"19","author":"C Dahlke","year":"2017","journal-title":"EBioMedicine"},{"issue":"Suppl 3","key":"ref31","doi-asserted-by":"crossref","first-page":"S757","DOI":"10.1093\/infdis\/jir296","article-title":"Reston ebolavirus in humans and animals in the Philippines: a review","volume":"204","author":"ME Miranda","year":"2011","journal-title":"J Infect Dis"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T09:14:59Z","timestamp":1589793299000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002402"}},"subtitle":[],"editor":[{"given":"Lorenz","family":"von Seidlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002402","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}